Medical Literature - 1973

Beck P, Willis D, Davies GT, Lachmann PJ, Sussman M 4/1973 Q.J.Med.

Apr;42(166):317-339.

Hereditary angioneurotic oedema is a rare condition inherited as an autosomal dominant and characterized by episodic circumscribed oedema of the skin, subcutaneous tissues, or mucous membranes. Life may be threatened when the pharynx or larynx are involved and oedema of the intestinal mucous membrane, presenting as colicky abdominal pain and vomiting, may lead to unnecessary surgical intervention. The condition is due to deficiency of the functional inhibitor of the activated first component of complement. Consumption of the inhibitor by activation of other plasma esterase systems permits spontaneous activation of the initial stages of the complement system and leads to the appearance of a kinin derived from the second component of complement which causes oedema by increasing vascular permeability.

Four patients in three generations of a family with hereditary angioneurotic oedema are presented with special reference to attacks of abdominal colic. The clinical and radiological appearances and serological changes are described before, during, and after treatment by transfusion of fresh-frozen plasma. It was confirmed that this, by replacing the inhibitor, is highly effective in terminating attacks without significant side-effects. It was also confirmed by a controlled trial that epsilon-aminocaproic acid acts prophylactically by reducing the frequency and severity of attacks of oedema.

Available online at: qjmed.oxfordjournals.org/content/42/2/317 (small fee)

Williamson DM. 5/1973 British Journal of Clinical Practice

May;27(5):193-195.

Not available online.

Ohela K, Rasanen JA, Wager O. 6/1973 Annals of Clinical Research

Jun;5(3):174-180.

Not available online.

Felix RH. 5/1973 Proceedings of the Royal Society of Medicine

May;66(5):437-438.

Available online at: ncbi.nlm.nih.gov/pmc/articles/PMC1644953/

7/1973 Lancet

Jul 7;2(7819):41.

Available online at: sciencedirect.com/science/article/pii/S0140673673919727 (small fee)

5/1973 Lancet

May 12;1(7811):1044-1045.

Available online at: sciencedirect.com/science/article/pii/S0140673673906752 (small fee)

Agostoni A, Martignoni GC. 8/1973 Lancet

2(7824):325

Available online at: sciencedirect.com/science/article/pii/S0140673673908313 (small fee)

Brackertz D, Kueppers F. 9/1973 Lancet

2(7830):680

Available online at: sciencedirect.com/science/article/pii/S0140673673925191 (small fee)

Calvert GD, Kilpatrick D, McQueen EG, Houston IB, Kilpatrick JA, Veale AM. 10/1973 N.Z.Med.J.

Oct 24;78(501):337-342.

Not available online.

Keller MF. 6/1973 Lancet

Jun 16;1(7816):1381-1382.

Available online at: sciencedirect.com/science/article/pii/S0140673673916966 (small fee)

Brackertz D, Kueppers F. 6/1973 Klin.Wochenschr.

51(12):620-622

The symptomatic therapy of hereditary angioneurotic edema with tranexamic acid and suramin in two patients is reported. The first patient responded well to tranexamic acid (Cyclocapron®) but not to suramin. In the second patient, attacks of edema could apparently be better prevented with suramin.

Available online at: link.springer.com/article/10.1007/BF01468576 (small fee)